Bloomios, Inc. Ceases Manufacturing At the Facility and Terminated All Employees
March 08, 2024 at 06:13 am EST
Share
Bloomios, Inc. announced that the Company has defaulted on the lease with its landlord for its manufacturing facility in Daytona Beach, Florida. Additionally, the Company has ceased manufacturing at the facility and terminated all employees at the facility. The Company is in the process of determining what will be done with the assets in the facility.
Bloomios, Inc. manufactures, markets, and distributes hemp-derived supplements and cosmetic products through wholesale distribution channels in the United States, through its wholly owned subsidiary, Bloomios Private Label (BPL). BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The Company manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. It provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. It offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.
BLOOMIOS, INC. 